Technical analysis of Septerna Inc (SEPN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
Price Performance
| 1 month | +14.07% |
| 3 months | +9.28% |
| Year-to-date | +54.95% |
| 1 year | +121.99% |
52-Week Range
| 52-week High | $51.10 |
| 52-week Low | $17.55 |
| Avg Volume (90d) | 423K |
Technical Indicators
| SMA 50 | $39.02 |
| SMA 200 | $32.16 |
| Beta | 3.50 |
| 30-day Volatility (annualised) | 51.0% |
| Price vs SMA 50 | +10.7% |
| Price vs SMA 200 | +34.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $27.88 | |
| 2026-01 | $23.34 | -16.3% |
| 2026-02 | $29.02 | +24.3% |
| 2026-03 | $24.03 | -17.2% |
| 2026-04 | $23.76 | -1.1% |
| 2026-05 | $30.20 | +27.1% |
| 2026-06 | $33.49 | +10.9% |
| 2026-07 | $34.45 | +2.9% |
| 2026-08 | $38.15 | +10.7% |
| 2026-09 | $39.13 | +2.6% |
| 2026-10 | $44.00 | +12.4% |
| 2026-11 | $43.20 | -1.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-09 | $-0.41 | $21M |
| 2026-08-10 | $-0.43 | $19M |
| 2026-05-12 | $-0.51 | $17M |
| 2026-03-09 | $-0.23 | $18M |
| 2025-11-10 | $0.19 | $17M |
| 2025-08-11 | $-0.05 | $5M |
| 2025-05-15 | $-0.38 | $30M |
Price
| Price | $43.70 (closing price, November 3, 2026) |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 5.09 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 4.99 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 3.34 |